Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
GLP1/GIP and the triple-agonist, promoting a sustained and significant decrease in body weight (8%), a marked reduction in fat tissue (40%) and food intake, as well as an improvement in glucose metabolism (Fig
Our personalized approach to diabetes and weight management ensures optimal efficacy and minimal side effects
As a triple agonist , it simultaneously activates three distinct receptor systems [5]: GIP (Glucose-dependent Insulinotropic Polypeptide) receptors enhance insulin secretion and may have direct effects on adipose tissue GLP-1 (Glucagon-like Peptide-1) receptors promote satiety, slow gastric emptying, and improve glucose regulation Glucagon receptors increase energy expenditure and may enhance fat oxidation This multi-receptor targeting strategy distinguishes retatrutide from single-pathway peptides and creates a complex metabolic profile that researchers are still working to fully characterize
Demographic breakdown shows that patients aged 40-65 represent the largest segment of GLP-1 users, though prescription rates are rising notably in younger adults seeking preventive metabolic support
If nausea persists beyond 8 weeks, talk to your PlexusDx providerthey may recommend a different dose schedule or combination therapy
Come talk to me about it
US$ 25.02
US$ 29.60
US$ 28.66
US$ 26.13
US$ 20.92
US$ 26.82
US$ 26.36
US$ 28.91
US$ 26.08
US$ 25.77
US$ 22.70
US$ 24.63
US$ 28.72
US$ 27.58
US$ 27.83
US$ 24.86
